News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aeras Global TB Vaccine Foundation and CanSino to Collaborate on TB Vaccine Development


5/7/2012 10:12:39 AM

2012-5-6--Tianjin CanSino Biotechnology Inc. and Aeras, a US-based non-profit, today announced a collaboration to advance the development of CanSino’s tuberculosis vaccine candidate. TB continues to be a major threat to global health, causing 1.4 million deaths worldwide annually. According to the terms of the agreement, Aeras will provide financial and technical support for CanSino’s non-human primate proof-of-concept study in China. More details…

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES